CGH
LKFT

Crossmark Global Holdings’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Crossmark Global Holdings’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Sell
10,538
-22,069
-68% -$627K ﹤0.01% 1041
2026
Q1 		$978K Sell
32,607
-370
-1% -$12.3K 0.01% 612
2025
Q4 		$1.08M Buy
32,977
+80
+0.2% +$2.58K 0.02% 577
2025
Q3 		$1.14M Sell
32,897
-14,545
-31% -$465K 0.02% 586
2025
Q2 		$1.33M Sell
47,442
-1,890
-4% -$50.7K 0.02% 537
2025
Q1 		$1.24M Buy
49,332
+169
+0.3% +$4.27K 0.02% 543
2024
Q4 		$1.35M Buy
49,163
+11,777
+32% +$328K 0.02% 490
2024
Q3 		$1.08M Buy
+37,386
New +$1.02M 0.02% 584
2021
Q2 		– Sell
-5,476
Closed -$422K – 1422
2021
Q1 		$422K Sell
5,476
-24
-0.4% -$2.21K 0.01% 997
2020
Q4 		$544K Buy
5,500
+530
+11% +$64.8K 0.01% 813
2020
Q3 		$705K Buy
4,970
+290
+6% +$48.3K 0.02% 644
2020
Q2 		$923K Buy
4,680
+294
+7% +$60.9K 0.03% 555
2020
Q1 		$859K Buy
4,386
+470
+12% +$101K 0.03% 505
2019
Q4 		$810K Sell
3,916
-204
-5% -$37.7K 0.02% 619
2019
Q3 		$629K Buy
+4,120
New +$675K 0.02% 701

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Crossmark Global Holdings's LKFT Position: Q2 2026 in Review

Crossmark Global Holdings reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 68% in Q2 2026, selling an estimated $627K and leaving 10,538 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #1041.

Crossmark Global Holdings first reported a position in LKFT in Q3 2019 and has held it in 15 quarters since. The position peaked at $1.35M in Q4 2024. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Crossmark Global Holdings held 10,538 shares of Lakefront Biotherapeutics American Depositary Shares worth $316K as of Q2 2026.
  • Crossmark Global Holdings sold 22,069 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $627K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #1041 holding.
  • Crossmark Global Holdings first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and has held it in 15 quarters since.
  • Crossmark Global Holdings's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.35M in Q4 2024.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.